By Brian Amaral ( August 1, 2016, 6:20 PM EDT) -- Third-party purchasers of a Novartis leukemia drug told a Massachusetts federal judge Monday that the company lied to patent examiners about how easy it was to come up with the $2 billion-a-year formulation, then violated antitrust law by engaging in "sham" litigation to protect its patent for another eight months....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.